A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Additional file 5: of APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC
Figure S4. Spiclomazine inhibitor does not sensitize HCC70 cells to Pt-compounds treatment. Histograms show the effect of co-treatments with CDDP (a, d, f) or CBDCA (b, c, e, g) and APE1/NPM1 inhibitors, Spiclomazine (a, b, d, e) and SB206553 (c, f, g)on HCC70 cells viability. Values express the mean viability ± SD from at least three independent replicates. Each value is normalized to the untreated condition. (PDF 81 kb)doi:10.6084/m9.figshare.8873795 fatcat:arksjcge4bacxorhrw6d5jmy5m